1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
The correlation between Piezo1 expression and clinicopathologic characteristics in 64 patients with glioblastomas
Characteristics Cases (No.) Expression of Piezo1 P Value Lowa (No.) Highb (No.) Cases (No.) 20 44 – Age (yr) 60 or older 12 4 8 .86 Younger than 60 52 16 36 Sex Male 36 12 24 .68 Female 28 8 20 Peritumoral brain edema No edema 0 0 0 .00 Mild edema 9 9 0 Moderate edema 16 5 11 Severe edema 39 6 33 Ki-67 index ≥40% 42 10 32 .08 <40% 22 10 12 IDH1 mutation No 50 16 34 .54 Yes 14 4 10 p53 status Negative 27 7 20 .43 Positive 37 13 24